Table 5 The most significant features within the patient adverse reactions after MODERNA vaccination for each target class.
No. of selected features | Selected features | |
|---|---|---|
Died | 36 | ['AGE_YRS', 'L_THREAT', 'PRIOR_VAX', 'OFC_VISIT', 'ER_ED_VISIT', 'ALLERGIES', 'VAX_DOSE_SERIES', 'HEADACHE', 'DYSPNOEA', 'FATIGUE', 'CHILLS', 'NAUSEA', 'COVID-19', 'MALAISE', 'COUGH', 'MYALGIA', 'CONDITION AGGRAVATED', 'PARAESTHESIA', 'PRURITUS', 'FACIAL PARALYSIS', 'PALPITATIONS', 'HYPERHIDROSIS', 'ERYTHEMA', 'THROAT TIGHTNESS', 'TREMOR', 'BLOOD PRESSURE INCREASED', 'INTENSIVE CARE', 'LOSS OF CONSCIOUSNESS', 'MUSCULAR WEAKNESS', 'FLUSHING', 'MOBILITY DECREASED', 'FEELING HOT', 'INJECTION SITE SWELLING', 'CEREBROVASCULAR ACCIDENT', 'CARDIAC ARREST', 'SARS-COV-2 TEST POSITIVE'] |
Hospitalized | 34 | ['AGE_YRS', 'SEX', 'L_THREAT', 'OTHER_MEDS', 'BIRTH_DEFECT', 'OFC_VISIT', 'ER_ED_VISIT', 'ALLERGIES', 'VAX_DOSE_SERIES', 'DISABLE', 'HEADACHE', 'PYREXIA', 'NAUSEA', 'COVID-19', 'PAIN IN EXTREMITY', 'COUGH', 'HYPOAESTHESIA', 'CHEST PAIN', 'RASH', 'PARAESTHESIA', 'PRURITUS', 'URTICARIA', 'FACIAL PARALYSIS', 'SYNCOPE', 'TACHYCARDIA', 'HYPERHIDROSIS', 'ERYTHEMA', 'TREMOR', 'INTENSIVE CARE', 'DECREASED APPETITE', 'INJECTION SITE ERYTHEMA', 'CARDIAC ARREST', 'LYMPHADENOPATHY', 'SARS-COV-2 TEST POSITIVE'] |
Recovered | 29 | ['SEX', 'L_THREAT', 'BIRTH_DEFECT', 'OFC_VISIT', 'ER_ED_VISIT', 'ALLERGIES', 'VAX_DOSE_SERIES', 'HEADACHE', 'CHILLS', 'PAIN', 'DIZZINESS', 'PAIN IN EXTREMITY', 'ASTHENIA', 'HYPOAESTHESIA', 'FEELING ABNORMAL', 'CHEST DISCOMFORT', 'ARTHRALGIA', 'PARAESTHESIA', 'UNRESPONSIVE TO STIMULI', 'PRURITUS', 'HEART RATE INCREASED', 'URTICARIA', 'TACHYCARDIA', 'THROAT TIGHTNESS', 'ANAPHYLACTIC REACTION', 'LOSS OF CONSCIOUSNESS', 'FLUSHING', 'INJECTION SITE SWELLING', 'CARDIAC ARREST'] |